Added to YB: 2024-07-03
Pitch date: 2024-03-31
GSK [bullish]
GSK plc
+23.58%
current return
Author Info
No bio for this author
Company Info
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
Market Cap
GBP 73.3B
Pitch Price
GBP 39.85
Price Target
N/A
Dividend
3.34%
EV/EBITDA
8.97
P/E
13.73
EV/Sales
2.71
Sector
Pharmaceuticals
Category
growth
Ariel Investments International (DM/EM) Portfolio Holding: GSK plc
GSK: Pharma stock up on strong vaccine sales & raised guidance. Transitioning to specialty meds & vaccines for growth & margins. Zantac litigation risk remains. Solid balance sheet enables bolt-on acquisitions for added growth potential.
Read full article (1 min)